Metraipolis › archive › dc_eeae56e36d64

Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody-drug conjugates, and clinical trial innovations — Europe PMC PMID:41626151

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41626151
DOI: 10.3389/fonc.2025.1697180
License (as archived): solo-consultazione
Archived: 2026-11-06T18:50:27.149Z
SHA-256 of the archived text: ef898fef4da66f899d32b142e6214abb1de527d2b64604862fc306a2564a4c11
Stable URL of this page: https://metraipolis.com/documento/dc_eeae56e36d64

How to cite

Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody-drug conjugates, and clinical trial innovations — Europe PMC PMID:41626151 — Europe PMC (en), https://europepmc.org/article/MED/41626151 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eeae56e36d64 (Metraipolis archive dc_eeae56e36d64, sha256 ef898fef4da66f899d32b142e6214abb1de527d2b64604862fc306a2564a4c11)

BibTeX

@misc{dceeae56e36d64,
  title = {Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody-drug conjugates, and clinical trial innovations — Europe PMC PMID:41626151},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41626151},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eeae56e36d64; sha256 ef898fef4da66f899d32b142e6214abb1de527d2b64604862fc306a2564a4c11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41626151. Agents can read the archived copy with the MCP tool read_document.